Sectors

ORMP
Oramed Pharmaceuticals Inc.
5.02
2 x 3.60
2 x 6.32
bid
ask
-
0.01
0.20%
2 @ 07:33 PM
4.96 -0.06 (1.20%)
Ytd76.14%
1y128.18%
4.91
day range
5.06
2.09
52 week range
5.47
Open5.03Prev Close5.03Low4.91High5.06Mkt Cap208.82M
Vol242.86KAvg Vol303.11KEPS4.12P/E1.22Forward P/E-29.75
Beta1.77Short Ratio2.60Inst. Own17.52%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1250-d Avg4.39200-d Avg3.671yr Est3.25

ORMP News

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
gurufocus.com
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
prnewswire.com
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan

Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million) Scilex (NASDAQ: SCL

Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
prnewswire.com
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes

NEW YORK, June 17, 2026 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www

Oramed Pharmaceuticals: 'Hold' On Oral Insulin Drug Failure Pivot And New Strategic Investment Direction
seekingalpha.com
Oramed Pharmaceuticals: 'Hold' On Oral Insulin Drug Failure Pivot And New Strategic Investment Direc

Oramed Pharmaceuticals is downgraded from 'Strong Buy' to 'Hold' due to the failed phase 3 trial for

Reviewing Oramed Pharmaceuticals (NASDAQ:ORMP) & Akanda (NASDAQ:AKAN)
defenseworld.net
Reviewing Oramed Pharmaceuticals (NASDAQ:ORMP) & Akanda (NASDAQ:AKAN)

Akanda (NASDAQ: AKAN - Get Free Report) and Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Report)

benzinga.com
Lifeward Closes The Strategic Partnership Agreement With Oramed Pharmaceuticals

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innova

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
Lifeward Shareholders Approve Issuance Of Ordinary Shares Over Previously Announced Collaboration De

Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innov

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
globenewswire.com
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Divers

Position s Lifeward as a diversified biomedical innovation company with clear path to profitability

Head to Head Review: GN Store Nord (OTCMKTS:GNNDY) and Oramed Pharmaceuticals (NASDAQ:ORMP)
defenseworld.net
Head to Head Review: GN Store Nord (OTCMKTS:GNNDY) and Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Report) and GN Store Nord (OTCMKTS:GNNDY - Get Free

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Above 50 Day Moving Average   – Here’s Why
defenseworld.net
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Above 50 Day Moving Average – Here’s Why

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP - Get Free Report)'s stock price passed above its 50-day m

Comparing QuidelOrtho (NASDAQ:QDEL) & Oramed Pharmaceuticals (NASDAQ:ORMP)
defenseworld.net
Comparing QuidelOrtho (NASDAQ:QDEL) & Oramed Pharmaceuticals (NASDAQ:ORMP)

QuidelOrtho (NASDAQ: QDEL - Get Free Report) and Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Rep

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above Fifty Day Moving Average   – Time to Sell?
defenseworld.net
Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above Fifty Day Moving Average – Time to Sell?

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP - Get Free Report)'s stock price crossed above its 50-day

benzinga.com
Lifeward To Issue $10M In Senior Secured Convertible Notes In A Private Placement, Of Which Oramed T

Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and

benzinga.com
UPDATE: Lifeward To Acquire Oramed's POD Technology And Secure Up To $47M Strategic Investment As Or

Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
globenewswire.com
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotec

Oramed and Lifeward Announce Strategic Transaction
prnewswire.com
Oramed and Lifeward Announce Strategic Transaction

Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and Pos

benzinga.com
Oramed Pharma Receives $18M Payment From Scilex Holdings, Representing $118M Total Returns On $99.5M

Payment Closes Out Option Agreement Obligations; Oramed Retains $39 Million Outstanding debt, Conver

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
prnewswire.com
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million;

Payment Closes Out Option Agreement Obligations; Oramed Retains $39 Million Outstanding debt, Conver

Reviewing Oramed Pharmaceuticals (NASDAQ:ORMP) & GE HealthCare Technologies (NASDAQ:GEHC)
defenseworld.net
Reviewing Oramed Pharmaceuticals (NASDAQ:ORMP) & GE HealthCare Technologies (NASDAQ:GEHC)

Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Report) and GE HealthCare Technologies (NASDAQ: GEHC

Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback
seekingalpha.com
Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback

Oramed remains viable after its flagship product failed FDA trials three years ago. Management ident

benzinga.com
Reported November 13, 2025: Oramed Pharmaceuticals Q3 EPS $1.26 Beats $(0.08) Estimate, Sales $2.000

Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly earnings of $1.26 per share which beat the a

Oramed Reports Fiscal Third Quarter 2025 Financial Results
prnewswire.com
Oramed Reports Fiscal Third Quarter 2025 Financial Results

Strong Nine-Month Performance Driven by Strategic Investment Portfolio; Total Assets Increase 42% to

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
prnewswire.com
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS

NEW YORK , Nov. 17, 2025 /PRNewswire/ -- The Board of Directors of Oramed Pharmaceuticals Inc. (the

Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
prnewswire.com
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Signi

Oramed Advancing Oral Insulin Program Independently; Announces Launch of New U.S. Trial  Diversified

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
Oramed Grants Scilex $27M Option To Repurchase Warrants, With Potential Note Extension To 2026

As previously disclosed, on September 21, 2023, Oramed Pharmaceuticals Inc. (the "Company")

benzinga.com
Oramed Pharma Closes Strategic Investment In Alpha Tau Medical; Oramed Affiliate Purchases About 14.

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the d

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
prnewswire.com
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau

Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
globenewswire.com
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alli

JERUSALEM, April 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”)

benzinga.com
Scilex Announces Voluntary $13.2M Early Payment On Oramed Note, Full Retirement Set For March 2025

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or the "Company"))), an innovative rev

benzinga.com
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 29 stocks made new 52-week lows.

benzinga.com
Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5%

U.S. stocks traded higher toward the end of trading, following the release of inflation data.

benzinga.com
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In T

Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company an

benzinga.com
US Stocks Turn Higher; Dow Jumps 200 Points

U.S. stocks turned higher midway through trading, following the release of inflation data.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 13 stocks hit new 52-week lows.

benzinga.com
Dow Drops 150 Points; US Inflation Rate Slows In December

U.S. stocks traded lower this morning, following the release of inflation data.

benzinga.com
Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket

Gainers Akerna Corp. (NASDAQ: KERN) rose 97.4% to $1.91 in pre-market trading after the company r

benzinga.com
Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's

U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s p

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 807 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 1043 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  Wednesday's session saw 784 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    On Monday, 721 companies achieved new lows for the year.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 431 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 160 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    On Monday, 466 companies hit new 52-week lows.

benzinga.com
52 Biggest Movers From Yesterday

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969.